MELASYL EFFICACY UNDER PART OF VISIBLE LIGHT
NCT06937515 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 31
Last updated 2025-04-22
Summary
The study intends to evaluate the efficacy of an anti-melanogenesis active in different concentrations under part of visible Light \[400-450nm\] exposures and under full visible light \[400-700nm\] exposures.
It is carried out on cosmetic products for which the safety has been assured by a toxicologist, with the aim of confirming the efficacy of the products, which will be used by a large number of consumers under normal and reasonably foreseeable use conditions.
Conditions
- Visible Light Exposure on Healthy Back Skin
Interventions
- OTHER
-
Cosmetic topical products
Cosmetic topical products efficacy evaluation
Sponsors & Collaborators
-
L'Oreal
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-03-27
- Primary Completion
- 2023-09-01
- Completion
- 2023-09-01
Countries
- Romania
More Related Trials
-
Efficacy and Tolerability of Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins
NCT06320314 ·Status: RECRUITING ·Phase: NA
-
Evaluate the Photoprotection Efficacy of Sunscreen Formulas Under Visible Light Exposure
NCT06796192 ·Status: COMPLETED
-
Evaluation of the Photoprotection Efficacy of Three Sunscreen Products Under Visible Light Exposure.
NCT06796205 ·Status: COMPLETED
-
Photoprotection Efficacy of Four Sunscreen Formulas Under Visible Light Exposure
NCT06796010 ·Status: COMPLETED
-
Photoprotection Efficacy With Sunscreen Formulas Containing the Cyclic Merocyanine Long-UVA Absorber MCE Under UV Day Light Exposure
NCT04866797 ·Status: UNKNOWN ·Phase: NA
-
Determine the Photoprotection Efficacy of Seven Sunscreen Products Under Visible Light Exposure.
NCT06796179 ·Status: COMPLETED
-
Evaluation of the Photoprotection Efficacy with Sunscreen Formulas Under Visible Light Exposure
NCT06803901 ·Status: COMPLETED
-
Efficacy of Methyl Aminolevulinate + Daylight in Patients With Facial Photodamage
NCT02139618 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Tolerability of Tested Formula After 3 Months of Treatment of Facial Hyperpigmentation of 3 Origins
NCT06253468 ·Status: RECRUITING ·Phase: NA
-
Evaluate the Photoprotection Efficiency of Sunscreen Formulas Under Visible Light Exposure
NCT06796088 ·Status: COMPLETED
-
Efficacy and Tolerability of the Tested Formula After 3 Months of Treatment of Facial Hyperpigmentation of 3 Origins
NCT06234527 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
To Assess the Photosensitisation and Photoallergy Potential of a Cosmetic Facial Product in Healthy Participants
NCT03183518 ·Status: COMPLETED ·Phase: NA
-
Trial of Methyl Aminolevulinate Plus Aktilite in Facial Photodamage
NCT00629317 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Oral Isotretinoin for Cutaneous Photodamage
NCT00842907 ·Status: UNKNOWN ·Phase: PHASE2
-
Ultraviolet and UV-Visible Light Photoprotection for the Treatment of Melasma
NCT01695356 ·Status: COMPLETED ·Phase: PHASE4
-
Performance of Different Application Regimens of ACTINICA® on Protection From UVR-induced Erythema After One Day of Sun Exposure in Fair-skinned Healthy Subjects.
NCT02251756 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema
NCT05300542 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Tolerability of the Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins
NCT06253455 ·Status: COMPLETED ·Phase: NA
-
Photoprotection Efficacy With Sunscreen Formulas Containing the Cyclic Merocyanine Long-UVA Absorber MCE, Under Real Sun Exposure
NCT04865055 ·Status: UNKNOWN ·Phase: NA
-
Oral Tranexamic Acid and Topical Hydroquinone in the Treatment of Melasma
NCT03751163 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Tolerability of the Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins
NCT06268496 ·Status: RECRUITING ·Phase: NA
-
Oral Isotretinoin for Photoaging: Results of a Randomized Controlled Phase II Trial
NCT00701740 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Potential Phototoxicity Skin Reaction After Use of MC2-01 Cream
NCT03892564 ·Status: COMPLETED ·Phase: PHASE1
-
Oral Isotretinoin in Melasma a Randomized Controlled Trial
NCT06201624 ·Status: RECRUITING ·Phase: PHASE1
-
Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases
NCT03340155 ·Status: UNKNOWN ·Phase: NA